On October 15, 2025 Yves Rideau, a pioneer of applied muscle research and a source of inspiration for many myologists, passed away in Poitiers, at the age of 87. 

This is a grave loss not only for the myology community, but also for the many patients, particularly those with Duchenne muscular dystrophy and their families. He dedicated his entire life to them, affirming and promoting the concept that "incurable" does not mean "untreatable," and seeking and finding solutions for every aspect of these conditions.

In the next issue of Acta Myologica, he will be given due recognition for his significant contributions to the treatment of Duchenne muscular dystrophy.